Creating Digital Biomarkers with Real-World and Existing Data

Temi della conferenza
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.

Professional congress organizer (PCO)
Dryfta

Mr. Andrew Juurinen